The association between human T-cell leukemia virus-1 (HTLV-1) and atherosclerosis remains to be determined. This case-control study aimed to investigate this association as measured by carotid intima-media thickness (CIMT). HTLV-1 infection was positively associated with CIMT, independent of atherosclerotic risks.
Similar to HIV-1, an Iranian case-control study reported an association between HTLV-1 and atherosclerosis as measured by CIMT [6] . Limitations in this prior study with small sample size prompted the current study in a large, older community-dwelling population in Japan.
METHODS

Study Settings and Participants
We conducted this nested case-control study using data from the Nagasaki Islands Study, which was a prospective cohort study performed in Goto City in the western islands of Japan [7] . The participants were recruited at medical check-ups, and members of the general population aged > 40 years living in Goto City were targeted for enrollment. The recruitment process has been described elsewhere [7] . The protocol for the Nagasaki Islands Study was approved by the Ethics Committee for the Use of Humans of Nagasaki University (project registration number: 14051404, 20141002-3; Nagasaki, Japan). Written informed consent was obtained from all participants. A total of 4428 participants were enrolled from 2014 to 2017. A total of 3070 subjects were included after exclusion of the following: age <60 years, history of stroke or ischemic heart disease, and missing data regarding blood pressure, CIMT, or HTLV-1 serostatus. Finally, a total of 2184 participants (810 men and 1374 women) with a mean age of 72.5 years (standard deviation, 7.2 years; range, 60-97 years) were evaluated.
Data Collection and Laboratory Measurements
Body weight and height were measured with an automatic body composition analyzer (BF-220; Tanita, Tokyo, Japan) at the time of phlebotomy, and the body mass index (BMI) was then calculated. Abdominal circumference was measured with an inelastic measuring tape that was placed over the skin at the level of the umbilical point. Trained medical technologists measured systolic blood pressure and diastolic blood pressure at rest using cuff oscillometry with a PASESA AVE-1500 (Shisei Datum, Tokyo, Japan). After coagulation, each blood samples were centrifuged and the serum was separated. Serum levels of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, creatinine, and glycated hemoglobin were measured using standard laboratory procedures. Trained interviewers obtained information on the participants' smoking status, alcohol intake, medical history, and use of antihypertensive agents, hypoglycemic agents, and lipid-lowering drugs. The smoking status and drinking status were categorized as "never, " "ex, " or "current. " The risk of atherosclerotic disease was estimated using the risk equation (Framingham-D' Agostino score) based on the Framingham study [8] . The Framingham-D' Agostino score includes age, total cholesterol, high-density lipoprotein cholesterol, and systolic blood pressure as quantitative variables, as well as sex, drug treatment for hypertension, smoking, and a history of diabetes mellitus as dichotomous variables.
Measurements of HTLV-1
A chemiluminescent enzyme immunoassay (CLEIA) kit (Fujirebio Inc., Tokyo, Japan) was used for HTLV-1 detection. As a confirmatory test, we used real-time reverse transcription polymerase chain reaction (RT-PCR) using the Hydrolysis probe method with the LightCycler 480 (Roshe, Basel, Schweiz). Sample DNA was purified from whole blood using GENE PREP STAR NA-480 (KURABO, Osaka, Japan). We additionally used Western blotting (Problot HTLV-1, Fujirebio Inc., Tokyo, Japan) for the real-time RT-PCR-negative cases.
Measurements of CIMT
Research doctors or laboratory technicians measured CIMT by ultrasonographic examination of the left and right carotid arteries using a LOGIQ Book XP with a 10-MHz transducer (GE Healthcare, Milwaukee, WI, USA) that was programmed with the CIMT measurement software Intimascope (Cross Media Ltd., Tokyo, Japan). The mean CIMT was calculated as the mean of the right and left CIMT measurements with carotid plaques excluded.
Statistical Analyses
Differences in mean values or proportions of variables by HTLV-1 positivity were analyzed by using the paired Student t-test for continuous variables, or the McNemar χ 2 test or the Wilcoxon signed-rank test for categorical variables. The mean CIMT met the assumptions of linear regression analysis, which justified using this analysis. In linear regression analysis, the association between HTLV-1 and CIMT was analyzed, and confounding of age and sex strongly attenuated this association. Therefore, further analysis was performed using HTLV-1-infected cases versus age-and sex-matched controls. Simple and multivariable linear regression analyses were performed to investigate the association between HTLV-1 and CIMT. We used a stepwise regression algorithm to build the multivariable model. Age, BMI, systolic blood pressure, glycated hemoglobin, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (continuous variables), sex (dichotomous variable), and smoking status (categorical variable; never, ex, current; 1, 2, 3, respectively) were included in the adjustment model 1. The Framingham-D' Agostino score (continuous variable) and BMI were included in model 2.
All P values for statistical tests were 2-tailed, and P < .05 was considered significant. All statistical analyses were performed using STATA v14 (StataCorp, College Station, TX, USA).
RESULTS
Among 2184 subjects, 406 (18.6%) HTLV-1-infected participants were detected using CLEIA. Of these 406 participants, 393 were positive for HTLV-1 by real-time RT-PCR. For the 13 real-time RT-PCR negative cases, western blotting showed that 8 cases were positive, 2 were negative, 2 were indeterminant, and 1 had a shortage of specimen. Finally, we detected 401 HTLV-1 Mean CIMT (mm) 0.72 ± 0.13 0.74 ± 0.14 .020
Data are shown as number (%) or mean ± standard deviation.
Abbreviation: CIMT, carotid intima-media thickness; N, number of the participants.
infected participants who remained for analysis. The characteristics of the 401 cases and 401 matched controls are shown in Table 1 . The atherosclerotic risks, including sex, smoking status, systolic blood pressure, glycated hemoglobin, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and the Framingham-D' Agostino score were not different between cases and controls. However, mean (standard deviation) CIMT was higher in cases (0.74 ± 0.14 mm) than in controls (0.72 ± 0.13 mm, P = .020). Mean age was older in cases than in controls (P = .030).
In linear regression analysis, the standardized ß coefficient was positively significant for HTLV-1 infection, age, male sex, smoking status, systolic blood pressure, and the Framingham-D' Agostino score (ß = 0.08, P = .031; ß = 0.39, P < .001; ß = 0.09, P = .010; ß = 0.10, P = .005; ß = 0.11, P = .002; and ß = 0.24, P < .001, respectively) (Supplementary Table 1 ). This coefficient was negatively significant for diastolic blood pressure and high-density lipoprotein cholesterol (ß = −0.08, P = .032 and ß = −0.08, P = .029, respectively).
In multivariable linear regression analysis, HTLV-1 infection was positively associated with CIMT after adjusting for age, sex, BMI, systolic blood pressure, glycated hemoglobin, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and smoking status (model 1, ß = 0.07, P = .028). This association was also positive after adjusting for the Framingham-D' Agostino score and BMI (model 2, ß = 0.08, P = .015).
DISCUSSION
This population-based study demonstrated an association between HTLV-1 infection and atherosclerotic risks. We found that HTLV-1 infection was positively associated with preclinical atherosclerosis as measured by CIMT, independent of atherosclerotic risk factors. Although an Iranian case-control study showed a positive association between HTLV-1 infection and CIMT [6] , the mean age of the participants was 42.9 years and mean CIMT was 0.52-0.57 mm. Therefore, this result is difficult to extrapolate to older populations and/or those with a higher mean CIMT.
A plausible mechanism of atherosclerosis induced by HTLV-1 infection might be related to inflammation. HTLV-1 preferentially infects into CD4+ T cells. However, HTLV-1 also infects synovial fibroblasts [9] , salivary epithelial cells [10] , and CD68+ macrophages [11] . Additionally, HTLV-1 enhances production of cytokines through activation of transcription factors or activators, such as nuclear factor-κB, cyclic AMP response element-binding protein (CREB) and CREB/activating transcription factor [12] . Increased expression of these molecules may be induced via activation of transcription factors by cytokines and chemokines in a bystander fashion [10] .
The major responsible cell types of atherosclerotic lesions are macrophages and endothelial cells in vivo. Therefore, HTLV-1 might be involved in functional alteration of macrophages and endothelial cells, resulting in augmentation of atherosclerosis. Further studies, including in situ examination of HTLV-1 or HTLV-1-related molecules, are required to investigate this possibility.
Another possible pathway of atherosclerosis induced by HTLV-1 is an overabundance of reactive oxygen species (ROS). HTLV-1 encodes viral structural genes of the pX region encoding tax, which increases production of ROS [13] . ROS are chemically unstable reactive free radicals and lead to endothelial dysfunction, which in turn progresses atherosclerosis [14] .
HIV-associated atherogenesis can be explained by the complicated interaction of HIV with host immune cells and endothelial cells, triggered by ROS, endoplasmic reticulum stress, inflammasome formation, and dysregulation of autophagy [15] . Further experimental studies focusing on these molecular mechanisms may be useful for understanding our results.
Limitations of our study include using cross-sectional data for exposure and outcome. Because effects of HTLV-1 infection on atherosclerosis are thought to be cumulative, a cohort study would be ideal to investigate this association.
In conclusion, HTLV-1 was associated with atherosclerosis as measured by CIMT in an older population in an area with high HTLV-1 seroprevalence. Screening for HTLV-1 infection might be beneficial for reducing viral transmission and for controlling cardiovascular risks for those with HTLV-1 infection.
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